Jane Street’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.57M | Sell |
275,800
-75,100
| -21% | -$325K | ﹤0.01% | 5602 |
|
|
2026
Q1 | $1.36M | Buy |
350,900
+28,100
| +9% | +$115K | ﹤0.01% | 5835 |
|
|
2025
Q4 | $1.35M | Sell |
322,800
-86,500
| -21% | -$335K | ﹤0.01% | 5540 |
|
|
2025
Q3 | $1.35M | Buy |
+409,300
| New | +$1.16M | ﹤0.01% | 5700 |
|
|
2025
Q2 | – | Sell |
-21,300
| Closed | -$31.7K | – | 10554 |
|
|
2025
Q1 | $31.7K | Buy |
+21,300
| New | +$33.5K | ﹤0.01% | 9083 |
|
|
2022
Q1 | – | Sell |
-30,600
| Closed | -$114K | – | 10859 |
|
|
2021
Q4 | $114K | Sell |
30,600
-40,000
| -57% | -$172K | ﹤0.01% | 9175 |
|
|
2021
Q3 | $352K | Sell |
70,600
-27,200
| -28% | -$157K | ﹤0.01% | 7881 |
|
|
2021
Q2 | $638K | Sell |
97,800
-4,300
| -4% | -$30K | ﹤0.01% | 6789 |
|
|
2021
Q1 | $703K | Buy |
102,100
+29,000
| +40% | +$245K | ﹤0.01% | 6166 |
|
|
2020
Q4 | $746K | Buy |
+73,100
| New | +$474K | ﹤0.01% | 5135 |
|
|
2020
Q3 | – | Sell |
-35,000
| Closed | -$175K | – | 7731 |
|
|
2020
Q2 | $175K | Buy |
+35,000
| New | +$119K | ﹤0.01% | 6452 |
|
|
2019
Q3 | – | Sell |
-17,400
| Closed | -$133K | – | 5577 |
|
|
2019
Q2 | $133K | Buy |
+17,400
| New | +$93.7K | ﹤0.01% | 4796 |
|
|
2018
Q4 | – | Sell |
-29,700
| Closed | -$511K | – | 5507 |
|
|
2018
Q3 | $511K | Sell |
29,700
-5,800
| -16% | -$86.3K | ﹤0.01% | 3593 |
|
|
2018
Q2 | $495K | Sell |
35,500
-33,400
| -48% | -$564K | ﹤0.01% | 3592 |
|
|
2018
Q1 | $1.06M | Buy |
+68,900
| New | +$985K | ﹤0.01% | 2592 |
|
|
2017
Q3 | – | Sell |
-18,400
| Closed | -$443K | – | 4916 |
|
|
2017
Q2 | $443K | Buy |
+18,400
| New | +$403K | ﹤0.01% | 3185 |
|
|
2017
Q1 | – | Sell |
-15,438
| Closed | -$372K | – | 4552 |
|
|
2016
Q4 | $372K | Buy |
15,438
+202
| +1% | +$5.62K | ﹤0.01% | 3146 |
|
|
2016
Q3 | $423K | Buy |
+15,236
| New | +$403K | ﹤0.01% | 2944 |
|
|
2016
Q2 | – | Sell |
-31,985
| Closed | -$1.07M | – | 4456 |
|
|
2016
Q1 | $1.07M | Buy |
+31,985
| New | +$1.01M | 0.01% | 1793 |
|
|
2015
Q4 | – | Sell |
-45,405
| Closed | -$1.43M | – | 4339 |
|
|
2015
Q3 | $1.43M | Buy |
45,405
+33,801
| +291% | +$1.65M | 0.01% | 1280 |
|
|
2015
Q2 | $561K | Buy |
11,604
+6,791
| +141% | +$286K | ﹤0.01% | 2166 |
|
|
2015
Q1 | $209K | Buy |
+4,813
| New | +$173K | ﹤0.01% | 2861 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Jane Street's PGEN Position: Q2 2026 in Review
Jane Street sold out of Precigen (PGEN) in Q2 2026, closing a stake of 1,821,790 shares — an estimated $7.87M sold.
Jane Street first reported a position in PGEN in Q4 2013 and held it in 31 quarters. The position peaked at $7.05M in Q1 2026. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Jane Street reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 1,821,790 Precigen shares in Q2 2026, an estimated $7.87M.
- Jane Street first reported a position in Precigen in Q4 2013 and held it in 31 quarters.
- Jane Street's Precigen position peaked at $7.05M in Q1 2026.
- 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.